Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Karn

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
The Journal of Infectious Diseases|August 16, 2021
A Phase 1/2 Randomized, Placebo-Controlled Trial of Romidespin in Persons With HIV-1 on Suppressive Antiretroviral TherapyDeborah K McMahon, Lu Zheng, Joshua C Cyktor, et al.
Retrovirology|January 16, 2022
Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in UgandaSamira Joussef-Piña, Immaculate Nankya, Sophie Nalukwago, et al.
The Journal of Infectious Diseases|October 30, 2018
Sex-Based Differences in Human Immunodeficiency Virus Type 1 Reservoir Activity and Residual Immune ActivationEileen P Scully, Monica Gandhi, Rowena Johnston, et al.
Journal of Virology|July 20, 2022
Detecting Sources of Immune Activation and Viral Rebound in HIV InfectionStephen W Wietgrefe, Lijie Duan, Jodi Anderson, et al.
Nature Medicine|February 1, 2022
Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trialJeffrey S Miller, Zachary B Davis, Erika Helgeson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2022
Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE TrialEileen P Scully, Evgenia Aga, Athe Tsibris, et al.
EMBO Molecular Medicine|July 21, 2021
Glycolysis downregulation is a hallmark of HIV-1 latency and sensitizes infected cells to oxidative stressIart Luca Shytaj, Francesco Andrea Procopio, Mohammad Tarek, et al.
NPJ Cardiovascular Health|March 3, 2026
Pre-exposure immunohematologic features of heart failure associate with COVID-19 mortalityDavid A Zidar, Brigid M Wilson, Sadeer G Al-Kindi, et al.
AIDS Research and Human Retroviruses|May 1, 2023
Current HIV/SIV Reservoir Assays for Preclinical and Clinical Applications: Recommendations from the Experts 2022 NIAID Workshop SummaryBrigitte E Sanders-Beer, Nancie M Archin, Zabrina L Brumme, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
The Journal of Infectious Diseases|August 16, 2021
A Phase 1/2 Randomized, Placebo-Controlled Trial of Romidespin in Persons With HIV-1 on Suppressive Antiretroviral TherapyDeborah K McMahon, Lu Zheng, Joshua C Cyktor, et al.
Retrovirology|January 16, 2022
Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in UgandaSamira Joussef-Piña, Immaculate Nankya, Sophie Nalukwago, et al.
The Journal of Infectious Diseases|October 30, 2018
Sex-Based Differences in Human Immunodeficiency Virus Type 1 Reservoir Activity and Residual Immune ActivationEileen P Scully, Monica Gandhi, Rowena Johnston, et al.
Journal of Virology|July 20, 2022
Detecting Sources of Immune Activation and Viral Rebound in HIV InfectionStephen W Wietgrefe, Lijie Duan, Jodi Anderson, et al.
Nature Medicine|February 1, 2022
Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trialJeffrey S Miller, Zachary B Davis, Erika Helgeson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2022
Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE TrialEileen P Scully, Evgenia Aga, Athe Tsibris, et al.
EMBO Molecular Medicine|July 21, 2021
Glycolysis downregulation is a hallmark of HIV-1 latency and sensitizes infected cells to oxidative stressIart Luca Shytaj, Francesco Andrea Procopio, Mohammad Tarek, et al.
NPJ Cardiovascular Health|March 3, 2026
Pre-exposure immunohematologic features of heart failure associate with COVID-19 mortalityDavid A Zidar, Brigid M Wilson, Sadeer G Al-Kindi, et al.
AIDS Research and Human Retroviruses|May 1, 2023
Current HIV/SIV Reservoir Assays for Preclinical and Clinical Applications: Recommendations from the Experts 2022 NIAID Workshop SummaryBrigitte E Sanders-Beer, Nancie M Archin, Zabrina L Brumme, et al.
Pageof 8